| ANN | Artificial neural network |
| AI | Artificial intelligence |
| API | Active pharmaceutical ingredient |
| ASP | Antisolvent precipitation |
| BWM | Ball wet milling |
| CESS® | Controlled expansion of supercritical solution |
| CMAs | Critical material attributes |
| CNS | Central nervous system |
| CPPs | Critical process parameters |
| CQAs | Critical quality attributes |
| 3D | Three-dimensional |
| Dexi | Dexibuprofen |
| DMT | Disease-modifying treatment |
| DRZ | Dorzolamide hydrochloride |
| EAE | Experimental autoimmune encephalomyelitis |
| EUD | Eudragit |
| FD | Freeze-dried |
| FDA | Food and Drug Administration |
| GA | Glatiramer acetate |
| GI | Gastrointestinal |
| hERG | Human ether-a-go-go-related gene |
| HME | Hot-melt extrusion |
| HPH | High-pressure homogenization |
| HPMC | Hydroxypropyl methylcellulose |
| IOP | Intraocular pressure |
| ISGS | In situ gelling system |
| MD | Molecular dynamics |
| MIMO | Multiple-input–multiple-output |
| MISO | Multiple-input–single-output |
| MF | Microfluidic technology |
| ML | Machine learning |
| MRE | Mean relative error |
| MS | Multiple sclerosis |
| NanoPRX | Nanoformed piroxicam |
| NN | Neural network |
| NAP | Naproxen |
| NBCD | Non-biological complex drug |
| PEO-PPO-PEO | Poly(ethylene oxide)-Poly(propylene oxide)-Poly(ethylene oxide) |
| PAL | Palmatine HCL |
| PAT | Process analytical technology |
| PDI | Polydispersity index |
| PVP | Polyvinyl pyrrolidone |
| QbD | Quality by design |
| RTD | Room temperature-dried |
| SDS | Sodium dodecyl sulfate |
| SVM | Support vector machines |
| SSE | Semi-solid extrusion |
| TEER | Transepithelial electrical resistance |
| TIM | Timolol maleate |
| TNF-α | Tumor necroses factor-α |